Cineworld Group - Full year 2021
17 March 2022 | 0 |
Overview
Operational Update:
All sites across the Group opened since June and operating with no restrictions since early March
Recovery has been driven by a strong slate of movies including record breaking Spider-Man: No Way Home, Shang-Chi and the Legend of the Ten Rings, Venom, and No Time to Die
January and February 2022 have been impacted by a record number of new COVID-19 cases due to the Omicron variant and lack of new releases
March started strong in light of decline in COVID-19 cases and outstanding performance of Batman
Key management actions taken during 2021:
Commercial initiatives: studio and landlord agreements
Operational measures: cash preservation, cinema reopening and permanent cost reduction
Financing initiatives: secured additional financing and covenant waivers
Business now well positioned to benefit from the strong movie slate in 2022 and beyond
1
Financial Review
FINANCIALS AT A GLANCE
H1 2021 | H2 2021 | FY 2021 | |
Admissions | 14m | 81m | 95m |
Revenue | $293m | $1,512m | $1,805m |
Adj. EBITDA | ($21m) | $476m | $455m |
Adj. EBITDAaL1 | ($103m) | $158m | $54m |
Note: on IFRS 16 basis
1) Adj. EBITDAaL refer to Adj. EBITDA net of Payment of lease liabilities | 3 |
Adj. Profit and Loss - IFRS 16
2021 | 2020 | 2019 | |||||
Revenue | $1,805m | $852m | $4,370m | COVID-19 materially impacted our results with cinemas partly closed | |||
Cost of sales | ($1,262m) | ($888m) | ($2,736m) | during the period | |||
Gross profit / (loss) | $543m | ($36m) | $1,634m | Excludes $127m impairment reversal charge | |||
G&A | ($88m) | ($103m) | ($103m) | ||||
Cash generated from JV | - | $23m | $50m | ||||
Adjusted EBITDA | $455m | ($115m) | $1,580m | Includes: cash contribution from JVs - no amounts received 2021 | |||
D&A1 | ($511m) | ($618m) | Excludes: | ||||
Adj. Operating (Loss) / Profit | ($56m) | ($733m) | $878m | - Transaction and reorganisation costs $38m | |||
- COVID-19 related costs of $2m | |||||||
Net finance costs2 | ($766m) | ($594m) | ($523m) | ||||
- Refinancing costs of $9m | |||||||
Adj. (Loss) / Profit before tax | ($823m) | ||||||
Tax charge | $167m | $414m | ($62m) | Net finance costs are: | |||
Adj. (Loss) /Profit after tax | ($656m) | ($913m) | $293m | - Net interest expense on bank loans of $273m (2020: $159m) | |||
Adjusted diluted EPS (cents) | (47.8c) | (66.5c) | 21.3c | - Lease interest (non-cash) of $445m (2020: $349m) | |||
Note: Please refer to note 2. Alternative Performance Measures | - Others (non cash) interest of $49m (2020: $86m) | ||||||
1) | Excludes amortisation of intangibles created on acquisition of $23.6m | ||||||
2) | Excludes Amendment fees for refinancing costs, Movement on financial derivatives, Recycle of net investment hedge, Foreign exchange translation gains and losses, Gain on extinguishment of debt, | 4 | |||||
remeasurement loss on financial instrument and Remeasurement of financial asset amortised cost |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Cineworld Group plc published this content on 17 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 March 2022 09:10:07 UTC.